<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36618501</PMID><DateRevised><Year>2023</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>A Potential Novel Treatment for Chronic Cough in Long COVID Patients: Clearance of Epipharyngeal Residual SARS-CoV-2 Spike RNA by Epipharyngeal Abrasive Therapy.</ArticleTitle><Pagination><StartPage>e33421</StartPage><MedlinePgn>e33421</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e33421</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.33421</ELocationID><Abstract><AbstractText>A major target of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the epipharyngeal mucosa. Epipharyngeal abrasive therapy (EAT) is a Japanese treatment for chronic epipharyngitis. EAT is a treatment for chronic epipharyngitis in Japan that involves applying zinc chloride as an anti-inflammatory agent to the epipharyngeal mucosa. Here, we present a case of a 21-year-old man with chronic coughing that persisted for four months after a diagnosis of mild coronavirus disease 2019 (COVID-19), who was treated by EAT. We diagnosed chronic epipharyngitis&#xa0;as the cause of the chronic cough after the SARS-CoV-2 infection. SARS-CoV-2 spike RNA had persisted in the epipharyngeal mucosa of this Long COVID patient. EAT was performed once a week for three months, which eliminated residual SARS-CoV-2 RNA and reduced epipharyngeal inflammation. Moreover, a reduction in the expression of proinflammatory cytokines was found by histopathological examination. We speculate that the virus was excreted with the drainage induced by EAT, which stopped the secretion of proinflammatory cytokines.&#xa0;This case study suggests that EAT is a useful treatment for chronic epipharyngitis involving long COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023, Nishi et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nishi</LastName><ForeName>Kensuke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Section of Otolaryngology, Department of Medicine, Fukuoka Dental College, Fukuoka, JPN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Otolaryngology, Faculty of Medicine, Fukuoka University, Fukuoka, JPN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Otolaryngology, Nishi Otolaryngology Clinic, Fukuoka, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshimoto</LastName><ForeName>Shohei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Section of Pathology, Department of Morphological Biology, Fukuoka Dental College, Fukuoka, JPN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oral Medicine Research Center, Fukuoka Dental College, Fukuoka, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Takayuki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Section of Otolaryngology, Department of Medicine, Fukuoka Dental College, Fukuoka, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kimura</LastName><ForeName>Shoichi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathology, Faculty of Medicine, Fukuoka University, Fukuoka, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shinchi</LastName><ForeName>Yudai</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Oral Dentistry, Fukuoka Dental College, Fukuoka, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamano</LastName><ForeName>Takafumi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Section of Otolaryngology, Department of Medicine, Fukuoka Dental College, Fukuoka, JPN.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">chronic cough</Keyword><Keyword MajorTopicYN="N">chronic epipharyngitis</Keyword><Keyword MajorTopicYN="N">epipharyngeal abrasive therapy</Keyword><Keyword MajorTopicYN="N">il-6</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">sars-cov-2 spike rna</Keyword><Keyword MajorTopicYN="N">tnf-&#x3b1;</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>9</Day><Hour>3</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36618501</ArticleId><ArticleId IdType="pmc">PMC9815934</ArticleId><ArticleId IdType="doi">10.7759/cureus.33421</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Long COVID: an overview. Raveendran AV, Jayadevan R, Sashidharan S. Diabetes Metab Syndr. 2021;15:869&#x2013;875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>A clinical case definition of post-COVID-19 condition by a Delphi consensus. Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. Lancet Infect Dis. 2022;22:0&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. Song WJ, Hui CK, Hull JH, Birring SS, McGarvey L, Mazzone SB, Chung KF. Lancet Respir Med. 2021;9:533&#x2013;544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8041436</ArticleId><ArticleId IdType="pubmed">33857435</ArticleId></ArticleIdList></Reference><Reference><Citation>Long lasting symptoms of dyspnea, cough and fatigue after COVID-19 - narrative review of epidemiological studies (Article in Polish) Marciniak E, G&#xf3;rniak A, Hanke W. Med Pr. 2021;72:711&#x2013;720.</Citation><ArticleIdList><ArticleId IdType="pubmed">34850782</ArticleId></ArticleIdList></Reference><Reference><Citation>The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection. Gallo O, Locatello LG, Mazzoni A, Novelli L, Annunziato F. Mucosal Immunol. 2021;14:305&#x2013;316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7690066</ArticleId><ArticleId IdType="pubmed">33244161</ArticleId></ArticleIdList></Reference><Reference><Citation>Epipharyngeal abrasive therapy down-regulates the expression of SARS-CoV-2 entry factors ACE2 and TMPRSS2. Nishi K, Yoshimoto S, Nishi S, et al. In Vivo. 2022;36:371&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8765169</ArticleId><ArticleId IdType="pubmed">34972736</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasopharyngeal reflexes: integrative analysis of evoked respiratory and cardiovascular effects. White SW, McRitchie RJ. Aust J Exp Biol Med Sci. 1973;51:17&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">4699547</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkinson disease affects peripheral sensory nerves in the pharynx. Mu L, Sobotka S, Chen J, et al. J Neuropathol Exp Neurol. 2013;72:614&#x2013;623.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3695629</ArticleId><ArticleId IdType="pubmed">23771215</ArticleId></ArticleIdList></Reference><Reference><Citation>Outcome of an outpatient specialty clinic for chronic epipharyngitis. Mogitate M, Sasaki Y, Komiyama A. https://doi.org/10.1016/j.anl.2020.09.019. Auris Nasus Larynx. 2021;48:451&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pubmed">33067050</ArticleId></ArticleIdList></Reference><Reference><Citation>Possible mechanisms underlying epipharyngeal abrasive therapy (EAT) with ZnCl2 solution for the treatment of autoimmune diseases and functional somatic syndrome. Hotta O, Inoue C, Tanaka A, Ieiri N. https://www.longdom.org/open-access/possible-mechanisms-underlying-epipharyngeal-abrasive-therapy-eat-with-znclsub2sub-solution-for-the-treatment-of-autoimm-16808.html Journal of Antivirals &amp; Antiretrovirals. 2017;9:81&#x2013;86.</Citation></Reference><Reference><Citation>Epipharyngeal abrasive therapy (EAT) reduces the mRNA expression of major proinflammatory cytokine IL-6 in chronic epipharyngitis. Nishi K, Yoshimoto S, Nishi S, et al. Int J Mol Sci. 2022;23</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9409341</ArticleId><ArticleId IdType="pubmed">36012469</ArticleId></ArticleIdList></Reference><Reference><Citation>Role of palatine tonsil and epipharyngeal lymphoid tissue in the development of glomerular active lesions (glomerular vasculitis) in immunoglobulin A nephropathy. Hotta O, Ieiri N, Nagai M, Tanaka A, Harabuchi Y. Int J Mol Sci. 2022;23</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8775943</ArticleId><ArticleId IdType="pubmed">35054911</ArticleId></ArticleIdList></Reference><Reference><Citation>Epipharyngeal abrasive therapy (EAT) has potential as a novel method for long COVID treatment. Imai K, Yamano T, Nishi S, et al. Viruses. 2022;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9147901</ArticleId><ArticleId IdType="pubmed">35632649</ArticleId></ArticleIdList></Reference><Reference><Citation>Exhaled nitric oxide levels are associated with the severity of chronic epipharyngitis and decreased via epipharyngeal abrasion. Mogitate M. https://doi.org/10.1016/j.anl.2022.11.003 Auris Nasus Larynx. 2022</Citation><ArticleIdList><ArticleId IdType="pubmed">36470741</ArticleId></ArticleIdList></Reference><Reference><Citation>Epipharyngeal abrasive therapy down-regulates the expression of Cav1.2: a key molecule in influenza virus entry. Nishi K, Yoshimoto S, Nishi S, et al. In Vivo. 2022;36:2357&#x2013;2364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9463883</ArticleId><ArticleId IdType="pubmed">36099101</ArticleId></ArticleIdList></Reference><Reference><Citation>Long-COVID treatments: why the world is still waiting. Ledford H. Nature. 2022;608:258&#x2013;260.</Citation><ArticleIdList><ArticleId IdType="pubmed">35945375</ArticleId></ArticleIdList></Reference><Reference><Citation>SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Stein SR, Ramelli SC, Grazioli A, et al. Nature. 2022;612:758&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Zollner A, Koch R, Jukic A, et al. Gastroenterology. 2022;163:495&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID: an inevitable sequela of SARS-CoV-2 infection. Lai CC, Hsu CK, Yen MY, Lee PI, Ko WC, Hsueh PR. https://doi.org/10.1016/j.jmii.2022.10.003 J Microbiol Immunol Infect. 2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9576029</ArticleId><ArticleId IdType="pubmed">36283919</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID in the Faroe islands: a longitudinal study among nonhospitalized patients. Petersen MS, Kristiansen MF, Hanusson KD, et al. Clin Infect Dis. 2021;73:0&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>